Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02524275 · TERMINATED
Trial details
- NCT number
- NCT02524275
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-30
- Primary completion
- 2021-10-28
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.